« Back
Home /
Apremilast

Apremilast

Item no.	M2030-5mg
Manufacturer	AbMole
CASRN	608141-41-9
Amount	5mg
Category	Oncology Neuroscience Neural Lineage Markers Neuroinflammation Metabolism Diabetes Glucose Homeostasis Cholesterol & Lipid Metabolism Aging & Neurological Disorders Inhibitors & Compound Libraries Small Molecules By Organ Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Purity	>99%
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	CC-10004
Similar products	Apremilast, CC-10004
Available
Target Information	PDE
Molecular Weight	460, 5
Solubility	DMSO 62 mg/mL
Bioactivity information	Apremilast is a novel, orally available small molecule inhibitor of PDE4 with IC50 of 74 nM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M2030-5mg-safety-datasheet.pdf